Substituted dihydrobenzofuran glycosidase inhibitors
US10995090B2 · kind B2 · utility
11Cited by
11References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2017 |
| Grant date | May 4, 2021 |
| Priority date | — |
| Expiry date | Nov 13, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I), wherein R′, R″, R, X, W, Q, n, and m have the meaning according to the claims, can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.